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Abstract
Purpose Favorable health outcomes among cancer survivors
are increasingly being attributed to lifestyle factors like phys-
ical activity, which is now promoted in clinical guidelines.
However, the available evidence indicates that physical activ-
ity may also reduce fatigue in this patient group. In this sys-
tematic review, we aimed to examine whether physical activ-
ity could reduce fatigue among survivors of colorectal cancer.
Methods The databases ofMedline, CINAHL, and PsycINFO
were systematically searched, using combinations of MeSH
and free-text terms for colorectal cancer, physical activity, and
fatigue. Randomized controlled trials and cohort studies with
longitudinal data collection were included. We performed a
random-effect meta-analysis.
Results Seven studies were included, five were randomized
controlled trials, and two were cohort studies. A meta-analysis
of the randomized controlled trials, which comprised 630 sur-
vivors in total, failed to show that physical activity had a
significant effect on fatigue (standardized mean differ-
ence = 0.21 (− 0.07 to 0.49)); however, reduced levels of
fatigue were observed in all studies. The results for the cohort
studies were inconclusive: one showed that increasing levels
of physical activity were significantly associated with decreas-
ing levels of fatigue; the other showed that decreasing levels
of fatigue were not associated with increasing levels of phys-
ical activity.
Conclusions Based on the data reviewed, we cannot draw
definitive conclusions about the effects of physical activity
on fatigue. None of the included studies were performed
among fatigued survivors of colorectal cancer. More research
is needed in this population, ensuring that the trials are appro-
priately powered to find differences in fatigue.
Keywords Colorectal neoplasms . Fatigue . Exercise .
Survivors . Physical activity
Introduction
Favorable health outcomes among cancer survivors are in-
creasingly being attributed to lifestyle factors, especially to
physical activity (PA), which is promoted in clinical guide-
lines [1]. PA has been shown to improve physical fitness [2]
and quality of life [3] and has been suggested to affect mor-
tality and recurrence rates favorably [4]. However, the latter
findings are based on observational evidence and need to be
interpreted with caution. Moreover, evidence suggests that PA
has the potential to reduce fatigue among survivors of cancer
[5], though most studies examining the effect of PA on fatigue
have been conducted among heterogeneous survivor groups
that mainly comprise survivors of breast cancer. Whether PA
is equally effective in reducing fatigue among survivors of
other cancers, such as colorectal cancer (CRC), has not been
thoroughly examined to date. This distinction is important
because these patients are generally older and have many
disease-specific side effects related to their treatments and
co-morbid conditions.
CRC is the third most common cancer worldwide, having
age-standardized incidence rates in developed countries of
36.3 and 23.6 per 100,000 for men and women, respectively
[6]. Mortality rates, however, are decreasing in these countries
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thanks to improved screening programs, treatments, and
follow-up regimes [6–8]. Consequently, the number of survi-
vors of CRC is expected to rise [9], which presents challenges
to the provision of follow-up care [10, 11]. Survivors of CRC
show a variety of late and long-term side effects, such as
bowel dysfunction [12], anorectal dysfunction, sexual dys-
function, and psychosocial problems [13], which can signifi-
cantly affect quality of life (QoL) and functioning.
A frequently occurring problem that affects QoL is cancer-
related fatigue [14], which is reported to be twice as prevalent
among survivors of CRC compared with an age- and gender-
matched reference population [15]. Moreover, it can persist
for a prolonged period, being present up to 10 years after
diagnosis [16, 17]. The relationship between PA and fatigue
has been studied in cross-sectional studies of CRC survivors,
indicating that higher levels of moderate-to-vigorous PA are
associated with lower levels of fatigue [18–21]. In other cross-
sectional research, it was also suggested that fatigue could
mediate the relation between PA and QoL [22]. Due to the
design of these studies, no conclusions can be made about
causality.
In this study, we aimed to conduct a systematic review of
the effect of posttreatment PA on fatigue among survivors of




The protocol for this review is available at PROSPERO, the
international database of prospectively registered systematic
reviews for health and social care (registration number
RD42015029702).
Eligibility criteria
Studies were included if they met the following criteria:
they must be a randomized clinical trial, controlled clin-
ical trial, or prospective cohort study; use longitudinal
data collection and analysis; report data about patients
with CRC; include patients treated with curative intent;
use a PA intervention (for the clinical trials) or an as-
sessment of PA (for the cohort studies); assess fatigue
using a validated fatigue questionnaire or a fatigue sub-
scale from a validated QoL questionnaire; and have the
data published in peer-reviewed journals.
Information sources and search strategy
The databases of Medline, CINAHL, and PsycINFO were
systematically searched in December 2015, using
combinations of MeSH and free-text words for Bcolorectal
cancer,^ Bphysical activity,^ and Bfatigue.^ Table 1 shows
the full search details for all databases; the search criteria were
combined with the BAND^ statement. No date restrictions or
language restrictions were defined a priori. In addition, we
checked the references of included studies for additional pub-
lications, and if necessary to obtain the relevant data, we
contacted the authors of studies that did not report the results
for CRC separately.
Data collection
Studies were screened for eligibility based on titles and ab-
stracts, after which full-text articles were reviewed, by two
researchers independently (DB and JK). Data collection was
performed in Microsoft® Access®, using a piloted and digi-
tized data extraction form. We identified authors, titles, study
types, populations, inclusion and exclusion criteria, interven-
tion details, questionnaires used, and outcomes measured.
Statistical analysis for meta-analysis of randomized
controlled trials
Because of expected heterogeneity of study participants,
interventions used, and timing of outcome measure-
ments, we used a random-effects model to pool the
effect of PA on fatigue. We calculated standardized
mean differences (SMDs) using mean scores and stan-
dard deviations at 6 months for the intervention and
control groups in all studies. When these data were
not available in the original articles, they were calculat-
ed by the researchers. When studies varied in time
points of measurement of outcomes, we used the
SMDs for the time points closest to 6 months.
Statistical heterogeneity was evaluated by the χ2 and
I2 tests and was determined statistically significant for
P < 0.1 and I2 > 50%, respectively.
Risk of bias assessment
Risk of bias assessment was performed using the Cochrane
collaboration’s risk of bias assessment tool for the controlled
trials [23] or the Newcastle–Ottawa quality assessment scale
for the cohort studies [24]. Two researchers (DB and JK)
independently reviewed the articles. Disagreement was calcu-
lated by Cohen’s kappa, and discrepancies were discussed
until consensus was reached, with arbitration by a third re-
searcher (AJB) when necessary. Publication bias was assessed
by evaluating a funnel plot. All analyses were conducted using
the computer program Review Manager (version 5.3.
Copenhagen, The Cochrane Collaboration, 2014).
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Results
Selection of articles
Figure 1 summarizes the search and article selection process.
In total, we found 1196 records and screened the titles and
abstracts of 1118 records after removing duplicates; agree-
ment between researchers was moderate (Cohen’s kappa of
0.558). After removing unsuitable articles, we screened 61 full
texts (Cohen’s kappa was 0.693, which was considered good),
which led to the exclusion of another 54 records. Therefore, 7
records were included for data extraction: 5 were RCTs (one
of which was a pilot), and 2 were cohort studies in which data
were analyzed prospectively [25–31].
Randomized controlled trials
Patients
Table 2 shows the characteristics of the five included RCTs. In
total, 630 CRC survivors were included, with sample sizes
ranging from 18 to 410 patients. The average ages of survivors
ranged from 57.3 to 69 years, most patients were male, and all
patients were included within 5 years after treatment. In all
studies but that by Pinto et al., patients with metastatic cancer
were excluded [28].
The baseline characteristics of the intervention and control
groups are summarized in Table 3. Mean ages ranged from
59.5 (11.2) to 68.7 (9.13) years in the intervention groups, and
Table 1 Search strategy for different databases
Medline/Pubmed CINAHL/PsycINFO
Colorectal cancer “Colorectal Neoplasms”[Mesh] OR
Colorectal cancer[tiab] OR
colorectal neoplasm*[tiab] OR






neoplasm*[tiab] OR cancer [tiab]
(MH “Colorectal Neoplasms+”) OR (MH “Colonic
Neoplasms+”)
OR TX (“colorectal cancer”) OR TX
(“colon cancer”) OR TX (“rectal cancer”)
Physical activity “Exercise”[Mesh] OR Exercise*[tiab]
OR physical activit*[tiab] OR
walk*[tiab] OR jog*[tiab] OR




training [tiab] OR sedentary
behavior [tiab]
(MH “Exercise+”) OR TX (“exercise”) OR (MH “Recovery,
Exercise”) OR (MH “Aerobic Exercises+”) OR (MH
“Resistance Training”) OR (MH “Therapeutic Exercise+”)
OR (MH “Aquatic Exercises”) OR (MH “Anaerobic
Exercises”) OR (MH “Exercise Intensity”) OR (MH
“Sports Nutritional Sciences”) OR (MH “Physical
Activity”) OR (MH “Activity Therapy (Iowa NIC)”) OR
(MH “Physical Activity (Omaha)”) OR (MH “Activity and
Exercise Enhancement (Iowa NIC)+”) OR (MH “Physical
Endurance+”) OR (MH “Physical Performance”) OR (MH
“Physical Fitness+”) ORTX (“Physical activity”) OR (MH
“Life Style Changes”) OR (MH “Life Style, Sedentary”)
OR TX (“Lifestyle”) OR ((DE “Physical Activity” OR DE
“Actigraphy” OR DE “Exercise” OR DE “Physical
Fitness”) OR (DE “Exercise” OR DE “Aerobic Exercise”




“Quality of Life”[Mesh] OR
Questionnaire*[tiab] OR
HRQOL[tiab] OR fatigue[tiab] OR
quality of life[tiab] OR qol[tiab] OR
daily activit*[tiab] OR
performance[tiab] OR
function*[tiab] OR health related
quality of life [tiab] OR tiredness
[tiab] OR FACT-F ORBFI OR FFIS
OR CFS OR FSI OR MFI OR
MFSI-SF OR EORTS QLQ-C30
OR CRDFS OR MAF OR FSS OR
FIB
(MH “Fatigue+”) OR TX (“Fatigue”) OR (MH “Cancer
Fatigue”) OR (MH “Mental Fatigue”)OR (MH “Quality of
Life+”) OR TX (“HRQoL”) OR TX (“QoL”) OR
TX(“Quality of Life”) OR TX (“Health Related Quality of
Life”) or TX (“tiredness”) ORTX (“performance”) OR (DE
“Fatigue”) OR (DE “Quality of Life” OR DE “Quality of
Work Life”)
Search strings for each part were combined using the “AND” Boolean statement
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from 55.6 (8.24) to 70.3 (8.7) years in the control groups. In
three of five studies [25–27], patients in the intervention
groups were younger than those in the control groups. Four
of five studies [25–28] included more women in the interven-
tion group (44–60%) compared to the control group (22.2–
54%).
Physical activity interventions
Interventions in the included RCTs (Table 2) ranged from
10 weeks to 36 months, with a median duration of 13 weeks.
Three interventions were home-based, requiring participants
to exercise themselves, and focused on either moderate car-
diovascular activity for up to 30 min 3–5 times per week [25,
28] or encouraging participants to increase their annual num-
ber of steps walked to 10,000 [27]. To enhance adherence, the
home-based programs used monitoring or counseling tele-
phone calls. The other two interventions consisted of super-
vised exercise sessions combined with advice for participants
to exercise in their own time [26, 30]. One intervention in-
volved a combination of cardiovascular exercise and resis-
tance training [26], whereas the other consisted of traditional
hatha yoga [30]. In most of the studies, controls received care
as usual, but, in one case, this was supplemented by weekly
calls to monitor symptoms and a survivorship tip sheet [28].
The study by Cramer et al. used patients on a waiting list as
their control population [30]. Dropout rates in included inter-
ventions ranged from 6 to 21%, with the larger studies having
larger dropout rates.
Outcome measures
The primary outcome measures are detailed in Table 2. All
RCTs used the Functional Assessment of Cancer Therapy-
Fatigue (FACT-F) questionnaire to measure fatigue as a sec-
ondary outcome measure. We contacted the corresponding
author of one study with unusual low fatigue scores, to find
out that the scores had been recoded [25]. We transformed
these scores back to the original scale and used them for the
meta-analysis.
The fatigue outcomes for the RCTs are summarized
in Table 3. All studies showed improvements in fatigue
scores from baseline to after the intervention. However,
the effect of the intervention on fatigue, when compared
with the control group, was only statistically significant
in one of the studies [26].
Figure 2 shows the results of the random-effects meta-anal-
ysis of the effect of the PA interventions on fatigue, which
Fig. 1 Flow diagram showing
the path of article selection
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confirmed that there was no significant effect on fatigue in
patients with treated CRC (SMD = 0.21 (− 0.07 to 0.49),
I2 = 42%, Z = 1.46, p = 0.14). No statistically significant
heterogeneity was found between the studies (χ2 = 6.95
(p = 0.14), I2 = 42%).
Risk of bias
Figure 3 depicts the risk of bias assessment for each included
RCT. Because participant and personnel blinding was not pos-
sible in these studies, blinding was evaluated based on that of
the outcome assessors. The studies by Hawkes et al. and
Cramer et al. were considered to have the lowest risks of bias
[27, 30], whereas the studies by Courneya et al. and Pinto et al.
had the highest risks of bias [25, 28]. These latter two studies
also scored high on other bias assessments. For example, con-
tamination (i.e., the control group also increased their levels of
PA) was an issue in the study by Courneya et al. [25], and
failure to obtain the required numbers based on the sample
size calculation was an issue in the study by Pinto et al. [28].




The two longitudinal cohort studies comprised 3904 patients
with CRC, and longitudinal data was available in 2828 of
these [29, 31]. Themean age of patients was 69.1 ± 9.42 years,
44.4% were female, and the average time since diagnosis was
5.2 ± 2.8 years. Most had non-metastatic CRC.
Outcomes
Both cohort studies measured fatigue using the Fatigue
Assessment Scale. The cohort study by van Putten et al.
(n = 2451) examined the correlation between PA and symp-
toms or function-related barriers (including fatigue), clinical
or sociodemographic variables [31]. While levels of
moderate-to-vigorous PAwere lower for fatigued CRC survi-
vors compared with those who were not, changes in fatigue
scores among survivors were not significantly associated with
changes in PA levels (β: − 0.25, 95% CI: − 0.50 to 0.01,
p = 0.05). The other cohort study by Husson et al.
(n = 1453) analyzed the course of fatigue and its correlates
[29]. However, this study did show that increased levels of
moderate-to-vigorous PA among CRC survivors were signif-
icantly associated with decreased levels of cancer-related fa-
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Quality assessment
The studies were performed using comparable methodology;
therefore, the quality assessments were comparable. In both
studies, participants were somewhat representative of the av-
erage CRC survivors in their communities (1 star), and the
exposed and non-exposed cohorts were also enrolled from
the same communities (1 star). Ascertainment of exposure
(fatigue or moderate-to-vigorous PA) was based on written
self-reporting (no star), as were the outcome assessments (no
star), and the outcome of interest could have been present at
the start of the study (no star). Both studies controlled for most
important factors (1 star) and had a sufficiently long follow-up
for the outcome to occur (1 star). Both studies suffered from
substantial loss to follow-up (approximately 60%), thereby
receiving no star for this criterion. Therefore, the studies
scored four out of eight possible stars.
Discussion
Summary
In this systematic review, we performed a meta-analysis of
five RCTs comprising 630 survivors of CRC. Interventions
based on increasing PA were shown not to have any signifi-
cant effect on fatigue levels. However, despite the lack of
statistical significance, a trend for reduced fatigue was ob-
served in all intervention groups.We considered the combined
effect not clinically relevant. Concerning the longitudinal co-
hort studies, one showed that increased levels of moderate-to-
vigorous PA were significantly associated with decreased fa-
tigue, but another showed that decreasing levels of fatigue
were not associated with increasing levels of PA.
Comparison with the literature
Our meta-analysis is the first to focus solely on the effects of
PA interventions on fatigue after treatment for CRC. Findings
from meta-analyses that included survivors of all types of
cancer showed that interventions to increase PA had signifi-
cant effects on fatigue [3, 32–34], as did a meta-analysis of
supervised exercise interventions among breast cancer
survivors [35]. However, most of the meta-analyses were
over-represented by breast cancer survivors, and they showed
considerable heterogeneity. A subgroup analysis in one meta-
analysis indicated that the results did not differ by type of
cancer [3], though this comparison was only between survi-
vors of breast cancer and survivors of other cancers, without
further specification of cancer type.
PA has been shown to be effective in reducing fatigue
among people who are healthy or have long-term conditions
[36, 37]. It has been hypothesized that PA can positively affect
key biological variables associated with fatigue in cancer sur-
vivors, including loss of skeletal muscle mass and strength,
anemia, increased proinflammatory cytokines levels, and
psycho-behavioral problems [38]. There is no reason to as-
sume that these should be radically different in survivors of
CRC.
A possible explanation for not finding an effect in this
meta-analysis is that none of the included trials was performed
among fatigued survivors. Average fatigue scores at baseline
ranged from 38.5 to 43, yet it is recommended that a score less
than 34 be used for the diagnosis of fatigue when using the
FACT-F [39]. Given that the scores observed in the included
studies were close to average fatigue scores in a normative
population (43.6 ± 9.4) [40], this may have led to ceiling
effects in the analyses. This was observed in earlier meta-
analyses [32]. Despite randomization protocols, the studies
in our meta-analysis (except the studies by Courneya et al.
[25] and Hawkes et al. [27]) showed higher FACT-F scores
in the intervention groups that could have led to even larger
ceiling effects.
In previous meta-analyses, the populations tended to be
younger compared with those in the current review. For ex-
ample, in the meta-analysis by Mishra et al. [3], the average
age varied ranged from 39 to 70 years, whereas it ranged from
60 to 69 in the current meta-analysis. It has been suggested
that older survivors of cancer benefit less from PA interven-
tions [41, 42], which is possibly related to lower adherence
among the elderly [43]. Further research is needed into the
optimal types of interventions designed to increase PA among
older survivors of cancer [41, 44].
Three of the five studies in our meta-analysis used home-
based exercise protocols with telephone monitoring, focusing
on aerobic exercise [25, 27, 28], while a fourth studied the
Fig. 2 Forest plot for the meta-analysis of the randomized controlled trial results
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effect of hatha yoga [30]. Earlier research suggested that the
effects of PA on fatigue were larger when the intensity of PA
was higher [34], and these four studies arguably did not in-
clude exercise of sufficient intensity. One trial that combined
aerobic and strength exercises, possibly leading to a higher
intensity, did show a significant effect. However, this was only
a pilot study and was not powered to assess the effects on
fatigue, indicating that the results need to be interpreted with
caution. It has been suggested that lower intensity intervention
might only offer beneficial effects if the exercise routines be-
come a part of daily life [34]. Considering the short duration of
most trials in our current meta-analysis, it is questionable
whether this could be assessed.
The results from the included cohort studies showed that
fatigue levels decreased when survivors of CRC increased
their moderate-to-vigorous PA. However, the other showed
that PA did not significantly increase when fatigue levels de-
creased. Thus, PA could positively affect fatigue, but it is
likely that other clinical or demographic variables have con-
founding effects. Although causality cannot be inferred from
observational research, selection bias was less of a problem
compared with the RCTs. This is particularly relevant because
the RCTs of the type we included were more likely to appeal
to survivors who were already interested or participating in
exercise, and because earlier research has shown that current
exercise status is the best predictor for adherence to exercise
interventions [45]. The opposite is true of fatigued survivors,
those who are not interested in PA, and those who feel more
ill, because such people may be less likely to accept an invi-
tation to participate in trials that require intense PA.
Strengths and weaknesses
Amajor strength of our review andmeta-analysis is that all the
included RCTs used the FACT-F questionnaire as the outcome
measure when assessing fatigue. The FACT-F has been shown
to be sensitive to changes over time [46, 47]. Indeed, although
earlier meta-analyses showed large heterogeneity in fatigue
outcomes, this was probably related to the differences in the
questionnaires used to evaluate fatigue [32, 34]. Also, we did
not limit the review to RCTs, which is important because these
are especially prone to selection bias in studies of PA, as
discussed. Other risks in trials of PA include selective attrition
and the potential for contamination, with the possibility that
Fig. 4 Funnel plot for
publication bias
Fig. 3 Risk of bias assessment of the randomized controlled trials
Support Care Cancer (2018) 26:393–403 401
participants randomized to the control group could improve
their PA, leading to further underestimation of the effect of the
intervention.
Heterogeneity was classified as moderate in our meta-
analysis (I2 = 41%), possibly because of the differences in
the types and intensities of PA, or because of the differences
in the timings of the outcome measures. We analyzed out-
comes that were measured between 6 weeks and 6 months
after the intervention, but earlier research has shown that the
effects of PA on fatigue varied between these time points. For
example, improvements have been seen at 12 weeks and be-
tween 3 and 6 months after intervention, but not at 6 months
[3]. Another noticeable weakness of our study was the small
number of included studies, making it impossible to perform
subgroup analyses to compare the effects of either aerobic and
strength exercises or self-guided and supervised exercise.
Conclusion
The results of this systematic review and meta-analysis do not
allow for definitive conclusions about the effect of PA on
fatigue among survivors of CRC. More research is needed
and should be conducted in trials powered to find differences
in the reduction of fatigue and that are performed among fa-
tigued survivors of CRC. However, considering the many
other beneficial effects of PA on fitness, QoL, and survival,
physicians should not hesitate to encourage survivors of CRC
to engage in more PA.
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